ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Jiha Kim
Matched on ORCID iD 0000-0001-9534-6888; OpenAlex author ID A5017174432; NIH RePORTER profile ID 12071679. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 28
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 grant
Papers 5
- Differential extracellular vesicle concentration and their biomarker expression of integrin αv/β5, EpCAM, and glypican-1 in pancreatic cancer models. Co-author DOI 10.1038/s41598-024-65209-8↗
- Single-Molecule Force Probing of RGD-Binding Integrins on Pancreatic Cancer Cells. Co-author DOI 10.1021/acsami.1c23361↗
- Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers14102448↗
- Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. First author DOI 10.1016/j.ccell.2021.02.007↗
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Co-author DOI 10.1038/nature16064↗
Grants 1
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yongki Choi · 3 shared papers, 1 shared grant, 2022–2026 · strength 1.02
- Grant Biostatistics and Bioinformatics Core Facility P20GM109024↗
- Paper Differential extracellular vesicle concentration and their biomarker expression of integrin αv/β5, EpCAM, and glypican-… DOI 10.1038/s41598-024-65209-8↗
- Paper Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Aden… DOI 10.3390/cancers14102448↗
- Sanku Mallik · 1 shared paper, 1 shared grant, 2022–2026 · strength 0.62
- Reed I. Jacobson · 3 shared papers, 2022–2024 · strength 0.56
- Paper Differential extracellular vesicle concentration and their biomarker expression of integrin αv/β5, EpCAM, and glypican-… DOI 10.1038/s41598-024-65209-8↗
- Paper Acquired αSMA Expression in Pericytes Coincides with Aberrant Vascular Structure and Function in Pancreatic Ductal Aden… DOI 10.3390/cancers14102448↗
- Paper Single-Molecule Force Probing of RGD-Binding Integrins on Pancreatic Cancer Cells. DOI 10.1021/acsami.1c23361↗
- Sathish Venkatachalem · 1 shared grant, 2026 · strength 0.46
- Megan Orr · 1 shared grant, 2026 · strength 0.46
- Mohiuddin Quadir · 1 shared grant, 2026 · strength 0.46
- Ang Guo · 1 shared grant, 2026 · strength 0.46
- Mark T Hamann · 1 shared grant, 2026 · strength 0.46
- Roberto Gomes · 1 shared grant, 2026 · strength 0.46
- Jagdish Singh · 1 shared grant, 2026 · strength 0.46
- Estelle Leclerc · 1 shared grant, 2026 · strength 0.46
- John Curlee Wilkinson · 1 shared grant, 2026 · strength 0.46
- Elisabetta Liverani · 1 shared grant, 2026 · strength 0.46
- Erxi Wu · 1 shared grant, 2026 · strength 0.46
- Bin Guo · 1 shared grant, 2026 · strength 0.46
- Katie M. Reindl · 1 shared grant, 2026 · strength 0.46
- Guodong Liu · 1 shared grant, 2026 · strength 0.46
- Rick J. Jansen · 1 shared grant, 2026 · strength 0.46
- Buddhadev Layek · 1 shared grant, 2026 · strength 0.46
- Lina Alhalhooly · 2 shared papers, 2022 · strength 0.33
- Randall E. Brand · 1 shared paper, 2024 · strength 0.23
- Raghu Kalluri · 2 shared papers, 2015–2021 · strength 0.19
- Paper Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic … DOI 10.1016/j.ccell.2021.02.007↗
- Paper Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. DOI 10.1038/nature16064↗
- Vikneshwari Natarajan · 1 shared paper, 2022 · strength 0.17
- Huamin Wang · 1 shared paper, 2021 · strength 0.14
- Yang Chen · 1 shared paper, 2021 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.